Format

Send to

Choose Destination
Sci Rep. 2016 Jan 20;6:19532. doi: 10.1038/srep19532.

Colorectal Cancer Screening Programme in Spain: Results of Key Performance Indicators After Five Rounds (2000-2012).

Author information

1
Cancer Prevention and Control Programme, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.
2
Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Spain.
3
Department of Clinical Sciences, University of Barcelona, Hospitalet de Llobregat, Barcelona, Spain.
4
Department of Gastroenterology, University Hospital of Bellvitge, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.
5
Department of Pharmacy, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.
6
Department of Fundamental Care and Medical-Surgical Nursing, University of Barcelona, Hospitalet de Llobregat, Barcelona, Spain.

Abstract

Effective quality assurance is essential in any screening programme. This article provides a unique insight into key quality indicators of five rounds of the first population-based colorectal cancer screening programme implemented in Spain (2000-2012), providing the results according to the type of screening (prevalent or first screen and incident or subsequent screen) and test (guaiac or immunochemical). The total crude participation rate increased from 17.2% (11,011) in the first round to 35.9% (22,988) in the last one. Rescreening rate was very high (88.6% in the fifth round). Positivity rate was superior with the faecal immunochemical test (6.2%) than with the guaiac-based test (0.7%) (p < 0.0001) and detection rates were also better with the immunochemical test. The most significant rise in detection rate was observed for high risk adenoma in men (45.5 per 1,000 screened). Most cancers were diagnosed at an early stage (61.4%) and there was a statistically significant difference between those detected in first or subsequent screening (52.6% and 70.0% respectively; p = 0.024). The availability of these results substantially improves data comparisons and the exchange of experience between screening programmes.

PMID:
26787510
PMCID:
PMC4726304
DOI:
10.1038/srep19532
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center